Randall T. Schapiro

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

Andrew Goodman, Theodore R. Brown, Lauren Krupp et al. · The Lancet · 2009 · 549 citations

Pharmacy, Neurology, Pharmacotherapy +8

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

Andrew Goodman, Theodore R. Brown, Keith R. Edwards et al. · Annals of Neurology · 2010 · 373 citations

Medicine, Pharmacology, Pharmacotherapy +12

Dose comparison trial of sustained-release fampridine in multiple sclerosis

Andrew Goodman, Ted R. Brown, J. A. Cohen et al. · Neurology · 2008 · 178 citations

Education, Pharmacotherapy, Clinical Pharmacology +16

Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis

Judy Soderberg, Thomas Y. Choi, Cheryl R. Hansen et al. · Archives of Physical Medicine and Rehabilitation · 1998 · 136 citations

Medicine, Neurology, Rehabilitation Medicine +13

Relationship of the Antispasticity Effect of Tizanidine to Plasma Concentration in Patients With Multiple Sclerosis

Patricia W. Nance, W. A. Sheremata, Sharon Lynch et al. · Archives of Neurology · 1997 · 74 citations

Medicine, Neurology, Pharmacology +11